Volume | 3,897,981 |
|
|||||
News | (1) | ||||||
Day High | 22.7899 | Low High |
|||||
Day Low | 20.84 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Corcept Therapeutics Inc | CORT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
21.322 | 20.84 | 22.7899 | 22.30 | 22.95 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
31,954 | 3,897,981 | $ 21.94 | $ 85,529,148 | - | 20.84 - 34.275 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:16:46 | formt | 1,576 | $ 22.30 | USD |
Corcept Therapeutics (CORT) Options Flow Summary
Corcept Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
2.31B | 103.52M | - | 482.38M | 106.14M | 1.03 | 21.76 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Corcept Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CORT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 23.50 | 23.65 | 20.84 | 23.00 | 858,501 | -1.20 | -5.11% |
1 Month | 24.74 | 26.10 | 20.84 | 24.35 | 782,539 | -2.44 | -9.86% |
3 Months | 21.79 | 26.10 | 20.84 | 23.35 | 1,091,820 | 0.51 | 2.34% |
6 Months | 27.79 | 33.28 | 20.84 | 24.67 | 1,172,211 | -5.49 | -19.76% |
1 Year | 22.46 | 34.275 | 20.84 | 25.50 | 916,314 | -0.16 | -0.71% |
3 Years | 23.31 | 34.275 | 15.825 | 23.16 | 865,762 | -1.01 | -4.33% |
5 Years | 11.90 | 34.275 | 9.55 | 20.16 | 956,160 | 10.40 | 87.39% |
Corcept Therapeutics Description
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. |